(Q38418118)

2 September 2017

title

Activation of an oncogenic TBC1D7 (TBC1 domain family, member 7) protein in pulmonary carcinogenesis (English)

1 reference

2 September 2017

1 reference

7

Yataro Daigo

1 reference

2 September 2017

Nagato Sato

1

1 reference

2 September 2017

Junkichi Koinuma

2

1 reference

2 September 2017

Tomoo Ito

3

1 reference

2 September 2017

Eiju Tsuchiya

4

1 reference

2 September 2017

Satoshi Kondo

5

1 reference

2 September 2017

Yusuke Nakamura

6

1 reference

2 September 2017

publication date

1 April 2010

1 reference

Genes, Chromosomes and Cancer

2 September 2017

published in

1 reference

2 September 2017

volume

49

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

353-367

1 reference

Identification and characterization of the tuberous sclerosis gene on chromosome 16

2 September 2017

cites work

1 reference

Molecular classification of breast carcinomas using tissue microarrays

21 January 2018

1 reference

7 January 2021

Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays

1 reference

7 January 2021

The role of ARF and Rab GTPases in membrane transport

1 reference

7 January 2021

A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples

1 reference

7 January 2021

From cancer genomics to thoracic oncology: discovery of new biomarkers and therapeutic targets for lung and esophageal carcinoma

1 reference

7 January 2021

HJURP is a cell-cycle-dependent maintenance and deposition factor of CENP-A at centromeres

1 reference

7 January 2021

Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer

1 reference

7 January 2021

Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis

1 reference

7 January 2021

Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis

1 reference

7 January 2021

Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.

1 reference

7 January 2021

The TSC1-TSC2 complex is required for proper activation of mTOR complex 2

1 reference

7 January 2021

ADAM8 as a novel serological and histochemical marker for lung cancer

1 reference

7 January 2021

Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers

1 reference

7 January 2021

Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer

1 reference

7 January 2021

Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas

1 reference

7 January 2021

Cancer statistics, 2008

1 reference

7 January 2021

Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839).

1 reference

7 January 2021

A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis

1 reference

7 January 2021

Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer

1 reference

7 January 2021

Activation of Holliday junction recognizing protein involved in the chromosomal stability and immortality of cancer cells

1 reference

7 January 2021

Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patients

1 reference

7 January 2021

Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

1 reference

7 January 2021

Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer

1 reference

7 January 2021

Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.

1 reference

7 January 2021

Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer

1 reference

7 January 2021

The TRE17 oncogene encodes a component of a novel effector pathway for Rho GTPases Cdc42 and Rac1 and stimulates actin remodeling

1 reference

7 January 2021

Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma

1 reference

7 January 2021

A shared domain between a spindle assembly checkpoint protein and Ypt/Rab-specific GTPase-activators

1 reference

7 January 2021

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

1 reference

7 January 2021

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

7 January 2021

Erlotinib in previously treated non-small-cell lung cancer

1 reference

7 January 2021

Molecular biology of lung cancer

1 reference

7 January 2021

Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy

1 reference

7 January 2021

ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway

1 reference

7 January 2021

Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer

1 reference

7 January 2021

The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer

1 reference

7 January 2021

Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer

1 reference

7 January 2021

Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer

1 reference

7 January 2021

Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas

1 reference

7 January 2021

Rab proteins as membrane organizers

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20747

1 reference

2 September 2017

1 reference